Clinical
RSSArticles
-
Very Low-carbohydrate Ketogenic Diet May Reverse Type 2 Diabetes
A very low-carbohydrate ketogenic diet demonstrated superiority to the plate method diet recommended by the American Diabetes Association for controlling and even reversing type 2 diabetes.
-
No Single Solution to Prevent Medication Nonadherence
Simple, low-cost reminder pill bottles did not lead to more improvement in medication adherence in patients with documented poor adherence.
-
What Are Your Patients ‘Hearing’ About Menopausal Hormonal Therapy?
Data from the prospective Nurses’ Health Study demonstrate a weak association between menopause onset after age 50 years and use of hormone therapy and hearing loss. The most likely explanation is “noise.”
-
Genital HPV in Men: How Common Is It?
In this U.S. cross-sectional survey, the prevalence of genital human papillomavirus (HPV) infection in adult men was 45%, of which 25% were high-risk subtypes. The overall rate of HPV vaccination among those who were eligible was 11%.
-
Don’t Forget About Functional Hypothalamic Amenorrhea
Functional hypothalamic amenorrhea is a common but often overlooked cause of menstrual dysfunction that remains a diagnosis of exclusion.
-
Maternal Mortality, Postpartum Hemorrhage, and Tranexamic Acid: The WOMAN Study
A multicenter study involving patients in 193 countries has shown a decrease in maternal mortality in women with postpartum hemorrhage who were given tranexamic acid once the diagnosis was made.
-
FDA Actions
In this section: FDA approves new amyotrophic lateral sclerosis, expands the indication for pembrolizumab, adds giant cell arteritis to the indication for tocilizumab, and green lights generic ADHD drug.
-
Ohio Attorney General Files Suit Against 5 Pharmaceutical Companies Over Opioids
The suit alleges fraudulent marketing that misled the state, prescribers, and patients about the risks of these medications.
-
Investigators Conclude Long-term Opioid Use Increases Dependency and Overdose Risks
Nationwide epidemic has raised questions regarding the long-term use of such medication for chronic pain conditions.
-
Researchers Offer Remedies for FDA’s Accelerated Approval Program
Once a drug receives accelerated approved, manufacturers are free to charge whatever they believe the market will bear without evidence that the drug affects disease progression.